People: Allergan Inc (AGN.N)

AGN.N on New York Stock Exchange

172.46USD
23 Jul 2014
Price Change (% chg)

$2.03 (+1.19%)
Prev Close
$170.43
Open
$169.22
Day's High
$172.99
Day's Low
$169.08
Volume
138,049
Avg. Vol
465,053
52-wk High
$174.48
52-wk Low
$86.96

Search Stocks

Gangolli, Julian 

Brief Biography

Mr. Julian S. Gangolli is Corporate Vice President and President, North America of Allergan Inc. Mr. Gangolli served as Senior Vice President, U.S. Eye Care from July 1998 to January 2004. Prior to joining Allergan, Mr. Gangolli served as Vice President, Sales and Marketing of VIVUS, Inc., a publicly-traded biopharmaceutical company, from 1994 to 1998, where he was responsible for facilitating the transition of the company from a research and development start-up into a niche pharmaceutical company. Prior to that, Mr. Gangolli served in a number of increasingly senior marketing roles in the UK, Global Strategic Marketing and in the US for Syntex Pharmaceuticals, Inc., a multinational pharmaceutical company. Mr. Gangolli began his career in pharmaceutical sales and marketing with Ortho-Cilag Pharmaceuticals, Ltd. a UK subsidiary of Johnson & Johnson. Mr. Gangolli received a BSc (Honors) in Applied Chemistry and Business Studies from Kingston Polytechnic in England.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
900,992 -- 1,739,900 2,640,890

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 52,500 2,957,780.00
Name Fiscal Year Total

David Pyott

12,029,300

Douglas Ingram

3,576,040

Jeffrey Edwards

3,064,560

Scott Whitcup

2,913,090

Arnold Pinkston

--

Scott Sherman

--
As Of 30 Dec 2013
Search Stocks